Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK)

Journal of Neurochemistry

Volumn 90, Issue 2, 2004, Pages 352-358

  Yoshida, Hirotaka ^a   Hastie, C James ^b   McLauchlan, Hilary ^b   Cohen, Philip ^b   Goedert, Michel ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

c Jun N terminal kinase; Stress activated protein kinase; Tau protein; Tauopathy

Indexed keywords

EPITOPE; ISOPROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN SERINE THREONINE KINASE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; HUMAN TISSUE; MICROFILAMENT; MICROTUBULE ASSEMBLY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; TAUOPATHY;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EPITOPES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOBLOTTING; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 10; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; TAU PROTEINS;

EID: 3142712947     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02479.x     Document Type: Article

References (50)

1. Allen B., Ingram E., Takao M. et al. (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22, 9340-9351.
2. Atzori C., Ghetti B., Piva R., Srinivasan A. N., Zolo P., Delisle M. B., Mirra S. S. and Migheli A. (2001) Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J. Neuropathol. Exp. Neurol. 60, 1190-1197.
3. Baumann K., Mandelkow E. M., Biemat J., Piwnica-Worms H. and Mandelkow E. (1993) Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 336, 417-424.
4. Bramblett G. T., Goedert M., Jakes R., Merrick S. E., Trojanowski J. Q. and Lee V. M.-Y. (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10, 1089-1099.
5. Buée-Scherrer V. and Goedert M. (2002) Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases in intact cells. FEBS Lett. 515, 151-154.
6. Buée-Scherrer V., Condamines O., Mourton-Gilles C., Jakes R., Goedert M., Pau B. and Delacourte A. (1996) AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Mol. Brain Res. 39, 79-88.
7. Drewes G., Lichtenberg-Kraag B., Döring F., Mandelkow E. M., Biernat J., Goris J., Dorée M. and Mandelkow E. (1992) Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11, 2131-2138.
8. Goedert M., Spillantini M. G., Jakes R., Rutherford D. and Crowther R. A. (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
9. 1. Implications for Alzheimer's disease. FEBS Lett. 312, 95-99.
10. Goedert M., Jakes R., Crowther R. A., Six J., Lübke U., Vandermeeren M., Cras P., Trojanowski J. Q. and Lee V. M.-Y. (1993) The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc. Natl Acad. Sci. USA 90, 5066-5070.
11. Goedert M., Jakes R., Crowther R. A., Cohen P., Vanmechelen E., Vandermeeren M. and Cras P. (1994) Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem. J. 301, 871-877.
12. Goedert M., Hasegawa M., Jakes R., Lawler S., Cuenda A. and Cohen P. (1997) Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett. 409, 57-62.
13. Goedert M., Jakes R. and Crowther R. A. (1999) Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett. 450, 306-311.
14. Gupta S., Barrett T., Whitmarsh A. J., Cavanagh J., Sluss H. K., Dérijard B. and Davis R. J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760-2770.
15. Hanger D. P., Hughes K., Woodgett J. R., Brion J. P. and Anderton B. H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62.
16. Hanger D. P., Betts J. C., Loviny T. L., Blackstock W. P. and Anderton B. H. (1998) New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. J. Neurochem. 71, 2465-2476.
17. Hasegawa M., Morishima-Kawashima M., Takio K., Suzuki M., Titani K. and Ihara Y. (1992) Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. J. Biol. Chem. 267, 17047-17054.
18. Hasegawa M., Jakes R., Crowther R. A., Lee V. M.-Y., Ihara Y. and Goedert M. (1996) Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein. FEBS Lett. 384, 25-30.
19. Hasegawa M., Smith M. J. and Goedert M. (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 437, 207-210.
20. Hutton M., Lendon C. L., Rizzu P. et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
21. Ishiguro K., Omori A., Takamatsu M., Sato K., Arioka M., Uchida T. and Imahori K. (1992) Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci. Lett. 148, 202-206.
22. Kanemaru K., Takio K., Miura R., Titani K. and Ihara Y. (1992) Fetal-type phosphorylation of the tau in paired helical filaments. J. Neurochem. 58, 1667-1675.
23. Kobayashi S., Ishiguro K., Omori A., Takamatsu M., Arioka M., Imahori K. and Uchida T. (1993) A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubules. FEBS Lett. 335, 171-175.
24. Kuan C. Y., Yang D. D., Samanta Roy D. R., Davis R. J., Rakic P. and Flavell R. A. (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667-676.
25. Kuan C. Y., Whitmarsh A. J., Yang D. D. et al. (2003) A critical role of neural-specific JNK3 for ischemic apoptosis. Proc. Natl Acad. Sci. USA 100, 15184-15189.
26. Kumagae Y., Zhang Y., Kim O. J. and Miller C. A. (1999) Human c-Jun N-terminal kinase expression and activation in the nervous system. Mol. Brain Res. 67, 10-17.
27. Ledesma M. D., Correas I., Avila J. and Diaz-Nido J. (1992) Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease. FEBS Lett. 308, 218-224.
28. Lee J. K., Park J., Lee Y. D., Lee S. H. and Han P. L. (1999) Distinct localization of SAPK isoforms in neurons of adult mouse brain implies multiple signaling modes of SAPK pathway. Mol. Brain Res. 70, 116-124.
29. Lee V. M.-Y., Goedert M. and Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159.
30. Lewis J., McGowan E., Rockwood J. et al. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402-405.
31. Lindwall G. and Cole R. D. (1984) Phosphorylation affects the ability of tau protein to promote microtubule assembly. J. Biol. Chem. 259, 5301-5305.
32. Lu P. J., Wulf G., Zhou X. Z., Davies P. and Lu K. P. (1999) The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399, 784-788.
33. Mandelkow E. M., Drewes G., Biemat J., Gustke N., Van Lint J., Vandenheede J. R. and Mandelkow E. (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 314, 315-321.
34. Matsuo E. S., Shin R. W., Billingsley M. L., Van de Voorde A., O'Connor M., Trojanowski J. Q. and Lee V. M.-Y. (1994) Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13, 989-1002.
35. Mercken M., Vandermeeren M., Lübke U., Six J., Boons J., Van de Voorde A., Martin J. J. and Gheuens J. (1992) Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol. (Berl). 84, 265-272.
36. Mohit A. A., Martin J. H. and Miller C. A. (1995) p493F12 kinase: a novel MAP kinase expressed in a subset of neurons in the human nervous system. Neuron 14, 67-78.
37. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Titani K. and Ihara Y. (1995) Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270, 823-829.
38. Noble W., Olm V., Takata K. et al. (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38, 555-565.
39. Poorkaj P., Bird T. D., Wijsman E., Nemens E., Garruto R. M., Anderson L., Andreadis A., Wiederholt W. C., Raskind M. and Schellenberg G. D. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815-825.
40. Reynolds C. H., Utton M. A., Gibb G. M., Yates A. and Anderton B. H. (1997) Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein. J. Neurochem. 68, 1736-1744.
41. Reynolds C. H., Betts J. C., Blackstock W. P., Nebreda A. R. and Anderton B. H. (2000) Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and p38, and glycogen synthase kinase-3β. J. Neurochem. 74, 1587-1595.
42. Sato S., Tatebayashi Y., Akagi T. et al. (2002) Aberrant tau phosphorylation by glycogen synthase kinase-3β and JNK3 induces oligomeric tau fibrils in COS-7 cells. J. Biol. Chem. 277, 42060-42065.
43. Scott C. W., Spreen R. C., Herman J. L., Chow F. P., Davison M. D., Young J. and Caputo C. B. (1993) Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly. J. Biol. Chem. 268, 1166-1173.
44. Spillantini M. G., Murrell J. R., Goedert M., Farlow M. R., Klug A. and Ghetti B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA 95, 7737-7741.
45. Woods Y. L., Cohen P., Becker W., Jakes R., Goedert M., Wang X. and Proud C. G. (2001) The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Be at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem. J. 355, 609-615.
46. Yoshida H. and Goedert M. (2002) Molecular cloning and functional characterization of chicken brain tau: isoforms with up to five tandem repeats. Biochemistry 41, 15203-152011.
47. Yoshida H. and Ihara Y. (1993) Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau. J. Neurochem. 61, 1183-1186.
48. Yoshida H., Crowther R. A. and Goedert M. (2002) Functional effects of tau gene mutations at ΔN296 and N296H. J. Neurochem. 80, 548-551.
49. Zheng-Fischhöfer Q., Biernat J., Mandelkow E. M., Illenberger S., Godemann R. and Mandelkow E. (1998) Sequential phosphorylation of Tau by glycogen synthase kinase-3β and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J. Biochem. 252, 542-552.
50. Zhu X., Raina A. K., Rottkamp C. A., Aliev G., Perry G., Boux H. and Smith M. A. (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76, 435-441.